FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947054080> ?p ?o ?g. }

• W2947054080 endingPage "e0007434" @default.
• W2947054080 startingPage "e0007434" @default.
• W2947054080 abstract "Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that is caused by a novel bunyavirus SFTSV. Currently our knowledge of the host-related factors that influence the pathogenesis of disease is inadequate to allow prediction of fatal outcome. Here we conducted a prospective study of the largest database on the SFTS patients, to identify the presence of comorbidities in SFTS, and estimate their effect on the fatal outcome. Among 2096 patients eligible for inclusion, we identified nine kinds of comorbidities, from which hyperlipidemia (12.2%; 95% CI: 10.8%–13.6%), hypertension (11.0%; 95% CI: 9.6%–12.3%), chronic viral hepatitis (CVH) (9.3%; 95% CI: 8.1%–10.5%), and diabetes mellitus (DM) (6.8%; 95% CI: 5.7%–7.9%) were prevalent. Higher risk of death was found in patients with DM (adjusted OR = 2.304; 95% CI: 1.520–3.492; P<0.001), CVH (adjusted OR = 1.551; 95% CI: 1.053–2.285; P = 0.026) and chronic obstructive pulmonary diseases (COPD) (adjusted OR = 2.170; 95% CI: 1.215–3.872; P = 0.009) after adjusting for age, sex, delay from disease onset to admission and treatment regimens. When analyzing the comorbidities separately, we found that the high serum glucose could augment diseases severity. Compared to the group with max glucose < 7.0 mmol/L, patients with glucose between 7.0–11.1 mmol/L and glucose ≥11.1 mmol/L conferred higher death risk, with the adjusted OR to be 1.467 (95% CI: 1.081–1.989; P = 0.014) and 3.443 (95% CI: 2.427–4.884; P<0.001). Insulin therapy could effectively reduce the risk of severe outcome in DM patients with the adjusted OR 0.146 (95% CI: 0.058–0.365; P<0.001). For CVH patients, severe damage of liver and prolongation of blood coagulation time, as well as high prevalence of bleeding phenotype were observed. These data supported the provocative hypothesis that treating SFTS related complications can attain potentially beneficial effects on SFTS." @default.
• W2947054080 created "2019-06-07" @default.
• W2947054080 creator A5011103330 @default.
• W2947054080 creator A5014656305 @default.
• W2947054080 creator A5016306625 @default.
• W2947054080 creator A5019560977 @default.
• W2947054080 creator A5026988751 @default.
• W2947054080 creator A5031564575 @default.
• W2947054080 creator A5038195995 @default.
• W2947054080 creator A5047906405 @default.
• W2947054080 creator A5048196920 @default.
• W2947054080 creator A5053202587 @default.
• W2947054080 creator A5056697635 @default.
• W2947054080 creator A5058506093 @default.
• W2947054080 creator A5071037763 @default.
• W2947054080 creator A5086044995 @default.
• W2947054080 creator A5087056235 @default.
• W2947054080 creator A5087380736 @default.
• W2947054080 creator A5088104037 @default.
• W2947054080 date "2019-05-28" @default.
• W2947054080 modified "2023-10-17" @default.
• W2947054080 title "Preexisting chronic conditions for fatal outcome among SFTS patients: An observational Cohort Study" @default.
• W2947054080 cites W1586154577 @default.
• W2947054080 cites W1899355388 @default.
• W2947054080 cites W1965398894 @default.
• W2947054080 cites W1975586699 @default.
• W2947054080 cites W1988374199 @default.
• W2947054080 cites W1999361409 @default.
• W2947054080 cites W2005359428 @default.
• W2947054080 cites W2007496527 @default.
• W2947054080 cites W2024745848 @default.
• W2947054080 cites W2047340788 @default.
• W2947054080 cites W2052882363 @default.
• W2947054080 cites W2085716301 @default.
• W2947054080 cites W2093703257 @default.
• W2947054080 cites W2099488507 @default.
• W2947054080 cites W2102978013 @default.
• W2947054080 cites W2105074740 @default.
• W2947054080 cites W2109816755 @default.
• W2947054080 cites W2128349139 @default.
• W2947054080 cites W2138781581 @default.
• W2947054080 cites W2146112506 @default.
• W2947054080 cites W2148441868 @default.
• W2947054080 cites W2158602615 @default.
• W2947054080 cites W2172114367 @default.
• W2947054080 cites W2508004219 @default.
• W2947054080 cites W2565478164 @default.
• W2947054080 cites W2594533768 @default.
• W2947054080 cites W2739174192 @default.
• W2947054080 cites W2748954736 @default.
• W2947054080 cites W2773348422 @default.
• W2947054080 cites W2802809951 @default.
• W2947054080 cites W2880576094 @default.
• W2947054080 cites W2884582828 @default.
• W2947054080 cites W2884802662 @default.
• W2947054080 cites W2886467789 @default.
• W2947054080 cites W2899748139 @default.
• W2947054080 cites W2900781853 @default.
• W2947054080 cites W4241322069 @default.
• W2947054080 doi "https://doi.org/10.1371/journal.pntd.0007434" @default.
• W2947054080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6555536" @default.
• W2947054080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31136581" @default.
• W2947054080 hasPublicationYear "2019" @default.
• W2947054080 type Work @default.
• W2947054080 sameAs 2947054080 @default.
• W2947054080 citedByCount "15" @default.
• W2947054080 countsByYear W29470540802019 @default.
• W2947054080 countsByYear W29470540802020 @default.
• W2947054080 countsByYear W29470540802021 @default.
• W2947054080 countsByYear W29470540802022 @default.
• W2947054080 countsByYear W29470540802023 @default.
• W2947054080 crossrefType "journal-article" @default.
• W2947054080 hasAuthorship W2947054080A5011103330 @default.
• W2947054080 hasAuthorship W2947054080A5014656305 @default.
• W2947054080 hasAuthorship W2947054080A5016306625 @default.
• W2947054080 hasAuthorship W2947054080A5019560977 @default.
• W2947054080 hasAuthorship W2947054080A5026988751 @default.
• W2947054080 hasAuthorship W2947054080A5031564575 @default.
• W2947054080 hasAuthorship W2947054080A5038195995 @default.
• W2947054080 hasAuthorship W2947054080A5047906405 @default.
• W2947054080 hasAuthorship W2947054080A5048196920 @default.
• W2947054080 hasAuthorship W2947054080A5053202587 @default.
• W2947054080 hasAuthorship W2947054080A5056697635 @default.
• W2947054080 hasAuthorship W2947054080A5058506093 @default.
• W2947054080 hasAuthorship W2947054080A5071037763 @default.
• W2947054080 hasAuthorship W2947054080A5086044995 @default.
• W2947054080 hasAuthorship W2947054080A5087056235 @default.
• W2947054080 hasAuthorship W2947054080A5087380736 @default.
• W2947054080 hasAuthorship W2947054080A5088104037 @default.
• W2947054080 hasBestOaLocation W29470540801 @default.
• W2947054080 hasConcept C126322002 @default.
• W2947054080 hasConcept C134018914 @default.
• W2947054080 hasConcept C188816634 @default.
• W2947054080 hasConcept C201903717 @default.
• W2947054080 hasConcept C203014093 @default.
• W2947054080 hasConcept C2522874641 @default.
• W2947054080 hasConcept C2776780178 @default.
• W2947054080 hasConcept C2778732662 @default.

• next